Global and United States Ketorolac Tromethamine Market Report & Forecast 2024-2031

Report ID: 1830349 | Published Date: Sep 2024 | No. of Page: 119 | Base Year: 2023 | Rating: 4.3 | Webstory: Check our Web story
1 Study Coverage
    1.1 Ketorolac Tromethamine Product Introduction
    1.2 Global Ketorolac Tromethamine Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Ketorolac Tromethamine Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Ketorolac Tromethamine Sales in Volume for the Year 2017-2028
    1.3 United States Ketorolac Tromethamine Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Ketorolac Tromethamine Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Ketorolac Tromethamine Sales in Volume for the Year 2017-2028
    1.4 Ketorolac Tromethamine Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Ketorolac Tromethamine in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Ketorolac Tromethamine Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Ketorolac Tromethamine Market Dynamics
        1.5.1 Ketorolac Tromethamine Industry Trends
        1.5.2 Ketorolac Tromethamine Market Drivers
        1.5.3 Ketorolac Tromethamine Market Challenges
        1.5.4 Ketorolac Tromethamine Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Ketorolac Tromethamine Market Segment by Type
        2.1.1 Injection
        2.1.2 Ophthalmic
        2.1.3 Nasal
        2.1.4 Oral tablet
    2.2 Global Ketorolac Tromethamine Market Size by Type
        2.2.1 Global Ketorolac Tromethamine Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Ketorolac Tromethamine Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Ketorolac Tromethamine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Ketorolac Tromethamine Market Size by Type
        2.3.1 United States Ketorolac Tromethamine Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Ketorolac Tromethamine Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Ketorolac Tromethamine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Ketorolac Tromethamine Market Segment by Application
        3.1.1 Short-term treatment of pain
        3.1.2 Ophthalmic Surgery
    3.2 Global Ketorolac Tromethamine Market Size by Application
        3.2.1 Global Ketorolac Tromethamine Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Ketorolac Tromethamine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Ketorolac Tromethamine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Ketorolac Tromethamine Market Size by Application
        3.3.1 United States Ketorolac Tromethamine Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Ketorolac Tromethamine Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Ketorolac Tromethamine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Ketorolac Tromethamine Competitor Landscape by Company
    4.1 Global Ketorolac Tromethamine Market Size by Company
        4.1.1 Top Global Ketorolac Tromethamine Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Ketorolac Tromethamine Revenue by Manufacturer (2017-2022)
        4.1.3 Global Ketorolac Tromethamine Sales by Manufacturer (2017-2022)
        4.1.4 Global Ketorolac Tromethamine Price by Manufacturer (2017-2022)
    4.2 Global Ketorolac Tromethamine Concentration Ratio (CR)
        4.2.1 Ketorolac Tromethamine Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Ketorolac Tromethamine in 2021
        4.2.3 Global Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Ketorolac Tromethamine Manufacturing Base Distribution, Product Type
        4.3.1 Global Ketorolac Tromethamine Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Ketorolac Tromethamine Product Type
        4.3.3 Date of International Manufacturers Enter into Ketorolac Tromethamine Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Ketorolac Tromethamine Market Size by Company
        4.5.1 Top Ketorolac Tromethamine Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Ketorolac Tromethamine Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Ketorolac Tromethamine Sales by Players (2020, 2021 & 2022)
5 Global Ketorolac Tromethamine Market Size by Region
    5.1 Global Ketorolac Tromethamine Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Ketorolac Tromethamine Market Size in Volume by Region (2017-2028)
        5.2.1 Global Ketorolac Tromethamine Sales in Volume by Region: 2017-2022
        5.2.2 Global Ketorolac Tromethamine Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Ketorolac Tromethamine Market Size in Value by Region (2017-2028)
        5.3.1 Global Ketorolac Tromethamine Sales in Value by Region: 2017-2022
        5.3.2 Global Ketorolac Tromethamine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Ketorolac Tromethamine Market Size YoY Growth 2017-2028
        6.1.2 North America Ketorolac Tromethamine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Ketorolac Tromethamine Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Ketorolac Tromethamine Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Ketorolac Tromethamine Market Size YoY Growth 2017-2028
        6.3.2 Europe Ketorolac Tromethamine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Ketorolac Tromethamine Market Size YoY Growth 2017-2028
        6.4.2 Latin America Ketorolac Tromethamine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Ketorolac Tromethamine Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Ketorolac Tromethamine Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporation Information
        7.1.2 Pfizer Description and Business Overview
        7.1.3 Pfizer Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Pfizer Ketorolac Tromethamine Products Offered
        7.1.5 Pfizer Recent Development
    7.2 Omeros Corporation
        7.2.1 Omeros Corporation Corporation Information
        7.2.2 Omeros Corporation Description and Business Overview
        7.2.3 Omeros Corporation Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Omeros Corporation Ketorolac Tromethamine Products Offered
        7.2.5 Omeros Corporation Recent Development
    7.3 Egalet US Inc.
        7.3.1 Egalet US Inc. Corporation Information
        7.3.2 Egalet US Inc. Description and Business Overview
        7.3.3 Egalet US Inc. Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Egalet US Inc. Ketorolac Tromethamine Products Offered
        7.3.5 Egalet US Inc. Recent Development
    7.4 Allergan
        7.4.1 Allergan Corporation Information
        7.4.2 Allergan Description and Business Overview
        7.4.3 Allergan Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Allergan Ketorolac Tromethamine Products Offered
        7.4.5 Allergan Recent Development
    7.5 Dr. Reddy’s Laboratories
        7.5.1 Dr. Reddy’s Laboratories Corporation Information
        7.5.2 Dr. Reddy’s Laboratories Description and Business Overview
        7.5.3 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Dr. Reddy’s Laboratories Ketorolac Tromethamine Products Offered
        7.5.5 Dr. Reddy’s Laboratories Recent Development
    7.6 Teva
        7.6.1 Teva Corporation Information
        7.6.2 Teva Description and Business Overview
        7.6.3 Teva Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Teva Ketorolac Tromethamine Products Offered
        7.6.5 Teva Recent Development
    7.7 Mylan
        7.7.1 Mylan Corporation Information
        7.7.2 Mylan Description and Business Overview
        7.7.3 Mylan Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Mylan Ketorolac Tromethamine Products Offered
        7.7.5 Mylan Recent Development
    7.8 West Ward Pharmaceuticals
        7.8.1 West Ward Pharmaceuticals Corporation Information
        7.8.2 West Ward Pharmaceuticals Description and Business Overview
        7.8.3 West Ward Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 West Ward Pharmaceuticals Ketorolac Tromethamine Products Offered
        7.8.5 West Ward Pharmaceuticals Recent Development
    7.9 Fresenius Kabi
        7.9.1 Fresenius Kabi Corporation Information
        7.9.2 Fresenius Kabi Description and Business Overview
        7.9.3 Fresenius Kabi Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Fresenius Kabi Ketorolac Tromethamine Products Offered
        7.9.5 Fresenius Kabi Recent Development
    7.10 Apotex
        7.10.1 Apotex Corporation Information
        7.10.2 Apotex Description and Business Overview
        7.10.3 Apotex Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Apotex Ketorolac Tromethamine Products Offered
        7.10.5 Apotex Recent Development
    7.11 Sandoz
        7.11.1 Sandoz Corporation Information
        7.11.2 Sandoz Description and Business Overview
        7.11.3 Sandoz Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 Sandoz Ketorolac Tromethamine Products Offered
        7.11.5 Sandoz Recent Development
    7.12 Amphastar Pharmaceuticals
        7.12.1 Amphastar Pharmaceuticals Corporation Information
        7.12.2 Amphastar Pharmaceuticals Description and Business Overview
        7.12.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 Amphastar Pharmaceuticals Products Offered
        7.12.5 Amphastar Pharmaceuticals Recent Development
    7.13 Gland Pharma Limited
        7.13.1 Gland Pharma Limited Corporation Information
        7.13.2 Gland Pharma Limited Description and Business Overview
        7.13.3 Gland Pharma Limited Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.13.4 Gland Pharma Limited Products Offered
        7.13.5 Gland Pharma Limited Recent Development
    7.14 Akorn
        7.14.1 Akorn Corporation Information
        7.14.2 Akorn Description and Business Overview
        7.14.3 Akorn Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.14.4 Akorn Products Offered
        7.14.5 Akorn Recent Development
    7.15 Sun Pharmaceutical
        7.15.1 Sun Pharmaceutical Corporation Information
        7.15.2 Sun Pharmaceutical Description and Business Overview
        7.15.3 Sun Pharmaceutical Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.15.4 Sun Pharmaceutical Products Offered
        7.15.5 Sun Pharmaceutical Recent Development
    7.16 Sagent Pharmaceuticals
        7.16.1 Sagent Pharmaceuticals Corporation Information
        7.16.2 Sagent Pharmaceuticals Description and Business Overview
        7.16.3 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.16.4 Sagent Pharmaceuticals Products Offered
        7.16.5 Sagent Pharmaceuticals Recent Development
    7.17 Aurobindo Pharma
        7.17.1 Aurobindo Pharma Corporation Information
        7.17.2 Aurobindo Pharma Description and Business Overview
        7.17.3 Aurobindo Pharma Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022)
        7.17.4 Aurobindo Pharma Products Offered
        7.17.5 Aurobindo Pharma Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Ketorolac Tromethamine Industry Chain Analysis
    8.2 Ketorolac Tromethamine Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Ketorolac Tromethamine Distributors
    8.3 Ketorolac Tromethamine Production Mode & Process
    8.4 Ketorolac Tromethamine Sales and Marketing
        8.4.1 Ketorolac Tromethamine Sales Channels
        8.4.2 Ketorolac Tromethamine Distributors
    8.5 Ketorolac Tromethamine Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer
List of Tables
    Table 1. Ketorolac Tromethamine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Ketorolac Tromethamine Market Trends
    Table 3. Ketorolac Tromethamine Market Drivers
    Table 4. Ketorolac Tromethamine Market Challenges
    Table 5. Ketorolac Tromethamine Market Restraints
    Table 6. Global Ketorolac Tromethamine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Ketorolac Tromethamine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Ketorolac Tromethamine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Ketorolac Tromethamine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Ketorolac Tromethamine Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Ketorolac Tromethamine Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Ketorolac Tromethamine Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Ketorolac Tromethamine Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Ketorolac Tromethamine Sales Share by Manufacturer, 2017-2022
    Table 15. Global Ketorolac Tromethamine Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Ketorolac Tromethamine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Ketorolac Tromethamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ketorolac Tromethamine as of 2021)
    Table 18. Top Players of Ketorolac Tromethamine in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Ketorolac Tromethamine Product Type
    Table 20. Date of International Manufacturers Enter into Ketorolac Tromethamine Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Ketorolac Tromethamine Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Ketorolac Tromethamine Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Ketorolac Tromethamine Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Ketorolac Tromethamine Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Ketorolac Tromethamine Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Ketorolac Tromethamine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Ketorolac Tromethamine Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Ketorolac Tromethamine Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Ketorolac Tromethamine Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Ketorolac Tromethamine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Ketorolac Tromethamine Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Ketorolac Tromethamine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Ketorolac Tromethamine Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Ketorolac Tromethamine Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Ketorolac Tromethamine Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Ketorolac Tromethamine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Ketorolac Tromethamine Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Ketorolac Tromethamine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Ketorolac Tromethamine Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Ketorolac Tromethamine Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Pfizer Corporation Information
    Table 43. Pfizer Description and Business Overview
    Table 44. Pfizer Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Pfizer Ketorolac Tromethamine Product
    Table 46. Pfizer Recent Development
    Table 47. Omeros Corporation Corporation Information
    Table 48. Omeros Corporation Description and Business Overview
    Table 49. Omeros Corporation Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Omeros Corporation Product
    Table 51. Omeros Corporation Recent Development
    Table 52. Egalet US Inc. Corporation Information
    Table 53. Egalet US Inc. Description and Business Overview
    Table 54. Egalet US Inc. Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Egalet US Inc. Product
    Table 56. Egalet US Inc. Recent Development
    Table 57. Allergan Corporation Information
    Table 58. Allergan Description and Business Overview
    Table 59. Allergan Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Allergan Product
    Table 61. Allergan Recent Development
    Table 62. Dr. Reddy’s Laboratories Corporation Information
    Table 63. Dr. Reddy’s Laboratories Description and Business Overview
    Table 64. Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Dr. Reddy’s Laboratories Product
    Table 66. Dr. Reddy’s Laboratories Recent Development
    Table 67. Teva Corporation Information
    Table 68. Teva Description and Business Overview
    Table 69. Teva Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Teva Product
    Table 71. Teva Recent Development
    Table 72. Mylan Corporation Information
    Table 73. Mylan Description and Business Overview
    Table 74. Mylan Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Mylan Product
    Table 76. Mylan Recent Development
    Table 77. West Ward Pharmaceuticals Corporation Information
    Table 78. West Ward Pharmaceuticals Description and Business Overview
    Table 79. West Ward Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. West Ward Pharmaceuticals Product
    Table 81. West Ward Pharmaceuticals Recent Development
    Table 82. Fresenius Kabi Corporation Information
    Table 83. Fresenius Kabi Description and Business Overview
    Table 84. Fresenius Kabi Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Fresenius Kabi Product
    Table 86. Fresenius Kabi Recent Development
    Table 87. Apotex Corporation Information
    Table 88. Apotex Description and Business Overview
    Table 89. Apotex Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Apotex Product
    Table 91. Apotex Recent Development
    Table 92. Sandoz Corporation Information
    Table 93. Sandoz Description and Business Overview
    Table 94. Sandoz Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Sandoz Product
    Table 96. Sandoz Recent Development
    Table 97. Amphastar Pharmaceuticals Corporation Information
    Table 98. Amphastar Pharmaceuticals Description and Business Overview
    Table 99. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Amphastar Pharmaceuticals Product
    Table 101. Amphastar Pharmaceuticals Recent Development
    Table 102. Gland Pharma Limited Corporation Information
    Table 103. Gland Pharma Limited Description and Business Overview
    Table 104. Gland Pharma Limited Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 105. Gland Pharma Limited Product
    Table 106. Gland Pharma Limited Recent Development
    Table 107. Akorn Corporation Information
    Table 108. Akorn Description and Business Overview
    Table 109. Akorn Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Akorn Product
    Table 111. Akorn Recent Development
    Table 112. Sun Pharmaceutical Corporation Information
    Table 113. Sun Pharmaceutical Description and Business Overview
    Table 114. Sun Pharmaceutical Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Sun Pharmaceutical Product
    Table 116. Sun Pharmaceutical Recent Development
    Table 117. Sagent Pharmaceuticals Corporation Information
    Table 118. Sagent Pharmaceuticals Description and Business Overview
    Table 119. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Sagent Pharmaceuticals Product
    Table 121. Sagent Pharmaceuticals Recent Development
    Table 122. Aurobindo Pharma Corporation Information
    Table 123. Aurobindo Pharma Description and Business Overview
    Table 124. Aurobindo Pharma Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Aurobindo Pharma Product
    Table 126. Aurobindo Pharma Recent Development
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Ketorolac Tromethamine Customers List
    Table 130. Ketorolac Tromethamine Distributors List
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Ketorolac Tromethamine Product Picture
    Figure 2. Global Ketorolac Tromethamine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Ketorolac Tromethamine Market Size 2017-2028 (US$ Million)
    Figure 4. Global Ketorolac Tromethamine Sales 2017-2028 (K Units)
    Figure 5. United States Ketorolac Tromethamine Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Ketorolac Tromethamine Market Size 2017-2028 (US$ Million)
    Figure 7. United States Ketorolac Tromethamine Sales 2017-2028 (K Units)
    Figure 8. United States Ketorolac Tromethamine Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Ketorolac Tromethamine Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Ketorolac Tromethamine Report Years Considered
    Figure 11. Product Picture of Injection
    Figure 12. Product Picture of Ophthalmic
    Figure 13. Product Picture of Nasal
    Figure 14. Product Picture of Oral tablet
    Figure 15. Global Ketorolac Tromethamine Market Share by Type in 2022 & 2028
    Figure 16. Global Ketorolac Tromethamine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Ketorolac Tromethamine Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Ketorolac Tromethamine Sales by Type (2017-2028) & (K Units)
    Figure 19. Global Ketorolac Tromethamine Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Ketorolac Tromethamine Price by Type (2017-2028) & (USD/Unit)
    Figure 21. United States Ketorolac Tromethamine Market Share by Type in 2022 & 2028
    Figure 22. United States Ketorolac Tromethamine Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Ketorolac Tromethamine Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Ketorolac Tromethamine Sales by Type (2017-2028) & (K Units)
    Figure 25. United States Ketorolac Tromethamine Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Ketorolac Tromethamine Price by Type (2017-2028) & (USD/Unit)
    Figure 27. Product Picture of Short-term treatment of pain
    Figure 28. Product Picture of Ophthalmic Surgery
    Figure 29. Global Ketorolac Tromethamine Market Share by Application in 2022 & 2028
    Figure 30. Global Ketorolac Tromethamine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Ketorolac Tromethamine Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Ketorolac Tromethamine Sales by Application (2017-2028) & (K Units)
    Figure 33. Global Ketorolac Tromethamine Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Ketorolac Tromethamine Price by Application (2017-2028) & (USD/Unit)
    Figure 35. United States Ketorolac Tromethamine Market Share by Application in 2022 & 2028
    Figure 36. United States Ketorolac Tromethamine Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Ketorolac Tromethamine Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Ketorolac Tromethamine Sales by Application (2017-2028) & (K Units)
    Figure 39. United States Ketorolac Tromethamine Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Ketorolac Tromethamine Price by Application (2017-2028) & (USD/Unit)
    Figure 41. North America Ketorolac Tromethamine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 42. North America Ketorolac Tromethamine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Ketorolac Tromethamine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 46. Europe Ketorolac Tromethamine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Ketorolac Tromethamine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 53. Asia-Pacific Ketorolac Tromethamine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Taiwan Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Philippines Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Ketorolac Tromethamine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 65. Latin America Ketorolac Tromethamine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Mexico Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Brazil Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Argentina Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Ketorolac Tromethamine Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Middle East & Africa Ketorolac Tromethamine Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. U.A.E Ketorolac Tromethamine Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Ketorolac Tromethamine Value Chain
    Figure 75. Ketorolac Tromethamine Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Omeros Corporation
Egalet US Inc.
Allergan
Dr. Reddy’s Laboratories
Teva
Mylan
West Ward Pharmaceuticals
Fresenius Kabi
Apotex
Sandoz
Amphastar Pharmaceuticals
Gland Pharma Limited
Akorn
Sun Pharmaceutical
Sagent Pharmaceuticals
Aurobindo Pharma
Frequently Asked Questions
Ketorolac Tromethamine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Ketorolac Tromethamine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Ketorolac Tromethamine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Adalimumab

Adalimumab market is segmented by region (country), players, by Type and by Application. Players, ... Read More

Eplerenone

Eplerenone market is segmented by region (country), players, by Type and by Application. Players, ... Read More

Paroxetine

Paroxetine market is segmented by region (country), players, by Type and by Application. Players, ... Read More